C
calliopehealthketamine
At Calliope Health Ketamine, we specialize in Spravato treatment and esketamine treatment for eligible patients who have not achieved adequate results with traditional antidepressant therapies. Spravato for depression is an FDA-approved treatment that uses esketamine, a medication derived from ketamine, and is administered under medical supervision. Our dedicated providers carefully evaluate each patient to determine whether esketamine for depression may be an appropriate option as part of a comprehensive mental health treatment plan.
Many individuals also inquire about Spravato for anxiety when exploring advanced mental health solutions. While Spravato is primarily approved for treatment-resistant depression, our clinical team works closely with patients to assess their symptoms and discuss available therapies that may support overall mental wellness. Every treatment plan is tailored to the unique needs and goals of the individual, ensuring a personalized approach to care.